These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26633515)

  • 1. Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy.
    Barbuti AM; Chen ZS
    Cancers (Basel); 2015 Dec; 7(4):2360-71. PubMed ID: 26633515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel in colon cancer management: from conventional chemotherapy to advanced nanocarrier delivery systems.
    Komal ; Nanda BP; Singh L; Bhatia R; Singh A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; ():. PubMed ID: 38990305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy.
    Xu JH; Hu SL; Shen GD; Shen G
    Cancer Cell Int; 2016; 16():13. PubMed ID: 26900348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxol (paclitaxel): mechanisms of action.
    Horwitz SB
    Ann Oncol; 1994; 5 Suppl 6():S3-6. PubMed ID: 7865431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options.
    Nunes M; Bartosch C; Abreu MH; Richardson A; Almeida R; Ricardo S
    Cells; 2024 May; 13(9):. PubMed ID: 38727322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling the mechanisms and challenges of cancer drug resistance.
    Khan SU; Fatima K; Aisha S; Malik F
    Cell Commun Signal; 2024 Feb; 22(1):109. PubMed ID: 38347575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN.
    Ma Q; Liu Z; Wang T; Zhao P; Liu M; Wang Y; Zhao W; Yuan Y; Li S
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients.
    Incze E; Mangó K; Fekete F; Kiss ÁF; Póti Á; Harkó T; Moldvay J; Szüts D; Monostory K
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-Based Drug Delivery: Translation from Bench to Clinic.
    Koh HB; Kim HJ; Kang SW; Yoo TH
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of dihydro-1
    Xu S; Sun Y; Wang P; Tan Y; Shi L; Chen J
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2247579. PubMed ID: 37587873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Tumors: Development, Drug Resistance, and Sensitization - An Epigenetic Approach.
    Sarkar S; Deyoung T; Ressler H; Chandler W
    Epigenetics; 2023 Dec; 18(1):2237761. PubMed ID: 37499114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the Flora of Saudi Arabia: Phytochemical and Biological Investigation of the Endangered Plant Species
    Fantoukh OI; Al-Hamoud GA; Nasr FA; Almarfadi OM; Hawwal MF; Ali Z; Alobaid WA; Binawad A; Alrashidi M; Alasmari F; Ahmed MZ; Noman OM
    Metabolites; 2023 Apr; 13(4):. PubMed ID: 37110214
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of cur ole of curcumin against paclitax cumin against paclitaxel-induced o el-induced oxidativ xidative stress and DNA damage in testes of adult male rats.
    Balcıoğlu E; Göktepe Ö; Tan FC; Bilgici P; Yakan B; Özdamar S
    Turk J Med Sci; 2023 Feb; 53(1):40-50. PubMed ID: 36945945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the parameters affecting the loading of anticancer drug Paclitaxel on coated gold nanoparticles for breast cancer treatment.
    Kharazmi A; Attaran N
    IET Nanobiotechnol; 2023 May; 17(3):234-245. PubMed ID: 36849875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cytotoxicity, loading, and release activity of paclitaxel loaded-porphyrin based metal-organic framework (PCN-600).
    Hamidian K; Barani M; Adeli-Sardou M; Sarani M; Daliran S; Oveisi AR
    Heliyon; 2023 Jan; 9(1):e12634. PubMed ID: 36647357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitoylethanolamide Mitigates Paclitaxel Toxicity in Primary Dorsal Root Ganglion Neurons.
    Elfarnawany A; Dehghani F
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachytherapy via a depot of biopolymer-bound
    Schaal JL; Bhattacharyya J; Brownstein J; Strickland KC; Kelly G; Saha S; Milligan J; Banskota S; Li X; Liu W; Kirsch DG; Zalutsky MR; Chilkoti A
    Nat Biomed Eng; 2022 Oct; 6(10):1148-1166. PubMed ID: 36261625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer.
    Xu T; Ma Q; Li Y; Yu Q; Pan P; Zheng Y; Li Z; Xiong X; Hou T; Yu B; Liu H; Sun Y
    Signal Transduct Target Ther; 2022 Oct; 7(1):354. PubMed ID: 36253371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Based on different immune responses under the glucose metabolizing type of papillary thyroid cancer and the response to anti-PD-1 therapy.
    Xie W; Zeng Y; Hu L; Hao J; Chen Y; Yun X; Lin Q; Li H
    Front Immunol; 2022; 13():991656. PubMed ID: 36211409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy - non-mitotic mechanisms of paclitaxel.
    Smith ER; Huang M; Schlumbrecht MP; George SHL; Xu XX
    Front Oncol; 2022; 12():907520. PubMed ID: 36185294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.